Published in Clin Ter on January 31, 1967
Amplifying effect of sumatriptan on noradrenaline venoconstriction in migraine patients. Cephalalgia (1993) 1.41
Hypothalamic modulation of nociception and reproduction in cluster headache. I. Therapeutic trials of leuprolide. Cephalalgia (1993) 1.30
Secretion, pain and sneezing induced by the application of capsaicin to the nasal mucosa in man. Br J Pharmacol (1988) 1.23
Hypothalamic modulation of nociception and reproduction in cluster headache. II. Testosterone-induced increase of sexual activity in males with cluster headache. Cephalalgia (1993) 1.17
A contribution to the interpretation of shock and pain in myocardial infarction. Mal Cardiovasc (1967) 1.13
Psychiatric comorbidity and psychosocial stress in patients with tension-type headache from headache centers in Italy. The Italian Collaborative Group for the Study of Psychopathological Factors in Primary Headaches. Cephalalgia (1999) 1.13
Lowered circannual urinary melatonin concentrations in episodic cluster headache. Cephalalgia (1994) 1.12
Visceral pain threshold is deeply lowered far from the head in migraine. Headache (1994) 1.06
An enzyme (MAO) defect on the platelets in migraine. Res Clin Stud Headache (1970) 1.04
Hyperresponsiveness of migraine patients to the hypotensive action of bromocriptine. Headache (1980) 0.98
Unilateral impairment of pupillary response to trigeminal nerve stimulation in cluster headache. Pain (1989) 0.96
Headache as possible expression of deficiency of brain 5-hydroxytryptamine (central denervation supersensitivity). Headache (1972) 0.94
Dopamine, the second putative protagonist in headache. Headache (1977) 0.91
[The test of venoconstriction for the measurement of sensitivity to 5-hydroxytryptamine and catecholamines in man]. Boll Soc Ital Biol Sper (1964) 0.90
An antaminic drug, BC 105, in the prophylaxis of migraine. Pharmacological, clinical, and therapeutic experiences. Int Arch Allergy Appl Immunol (1967) 0.90
The naloxone conjunctival test in morphine addiction. Eur J Pharmacol (1980) 0.89
Central cholinergic challenging of migraine by testing second-generation anticholinesterase drugs. Headache (2002) 0.88
Hypothesis: migraine, a central biochemical dysnociception. Headache (1976) 0.88
Enkephalinase inhibition relieves pain syndromes of central dysnociception (migraine and related headache). Cephalalgia (1981) 0.87
Systemic non-organic central pain: a new syndrome with decentralization supersensitivity. Headache (1978) 0.86
Sex, migraine and serotonin interrelationships. Monogr Neural Sci (1976) 0.86
Characterization of endopeptidase 3.4.24.11 ("enkephalinase") activity in human plasma and cerebrospinal fluid. Biochem Pharmacol (1990) 0.85
Ergotamine and methysergide as serotonin partial agonists in migraine. Headache (1976) 0.85
In vivo 'enkephalinase' inhibition by acetorphan in human plasma and CSF. Eur J Pharmacol (1986) 0.85
The central cholinergic system has a role in the antinociception induced in rodents and guinea pigs by the antimigraine drug sumatriptan. J Pharmacol Exp Ther (1996) 0.84
Unmasking latent dysnociception in healthy subjects. Headache (1987) 0.84
Does anisocoria by clonidine reflect a central sympathetic dysfunction in cluster headache? Clin Neuropharmacol (1988) 0.84
Fibromyalgia and headache. Failure of serotonergic analgesia and N-methyl-D-aspartate-mediated neuronal plasticity: their common clues. Cephalalgia (1998) 0.82
Endorphins, opiate receptors and migraine headache. Headache (1978) 0.82
Wine and migraine: compatibility or incompatibility? Drugs Exp Clin Res (1999) 0.81
Decentralization supersensitivity in headache and central panalgesia. Res Clin Stud Headache (1978) 0.81
Alpha and beta adrenergic receptors in human veins; activity of a new beta-blocking agent. Med Pharmacol Exp Int J Exp Med (1966) 0.81
Classification and diagnostic criteria for primary headache disorders (Ad Hoc Committee IHS, 1988). Funct Neurol (1989) 0.81
Pain relief by somatostatin in attacks of cluster headache. Pain (1984) 0.80
Morphine abstinence and serotonin supersensitivity in man: analogies with the mechanism of migraine? Psychopharmacology (Berl) (1979) 0.80
Oral sumatriptan compared with placebo in the acute treatment of migraine. J Neurol (1994) 0.80
5-hydroxytryptamine supersensitivity as a new theory of headache and central pain: a clinical pharmacological approach with p-chlorophenylalanine. Psychopharmacologia (1973) 0.80
Somatostatin: peripheral venoconstrictive activity and interaction with monoamines in man. Regul Pept (1987) 0.79
Analgesizing effect of a methyl donor (S-adenosylmethionine) in migraine: an open clinical trial. Int J Clin Pharmacol Res (1986) 0.79
Involvement of central cholinergic system in antinociception induced by sumatriptan in mouse. Int J Clin Pharmacol Res (1997) 0.79
Substance P and endogenous opioids: how and where they could play a role in cluster headache. Cephalalgia (1983) 0.79
Change in serotonin and catecholamines vascular reactivity during migraine attack. Res Clin Stud Headache (1970) 0.79
A new nonvascular interpretation of syncopal migraine. Adv Neurol (1982) 0.79
Latent dysautonomic pupillary lateralization in cluster headache. A pupillometric study. Cephalalgia (1982) 0.79
A statistical evaluation of the relationships between headache and internal frontal hyperostosis. Res Clin Stud Headache (1970) 0.79
Fenfluramine headache. Headache (1976) 0.79
Release of sensory neuropeptides from dural venous sinuses of guinea pig. Brain Res (1990) 0.78
[Clinical pharmacology of pindolol on vasomotor receptors]. Boll Soc Ital Biol Sper (1975) 0.78
Fibromyalgia and migraine, two faces of the same mechanism. Serotonin as the common clue for pathogenesis and therapy. Adv Exp Med Biol (1996) 0.78
Thiorphan increases capsaicin-evoked release of substance P from slices of dorsal spinal cord of guinea pig. Neurosci Lett (1989) 0.78
Acute oral captopril inhibits angiotensin converting enzyme activity in human cerebrospinal fluid. J Hypertens (1987) 0.78
Adrenergic supersensitivity of the pupil in idiopathic headache. Experientia (1977) 0.78
Substance P mechanism in cluster headache: evaluation in plasma and cerebrospinal fluid. Cephalalgia (1985) 0.78
Sexuality and headache. Adv Neurol (1982) 0.77
Enkephalinase and angiotensin converting enzyme activities in human venous and arterial plasma. Neuropeptides (1986) 0.77
Hypernociceptive syndromes and pharmacological inhibition of endogenous opioid degradation. Int J Clin Pharmacol Res (1986) 0.77
Phantom eye: features and prevalence. The predisposing role of headache. Cephalalgia (1997) 0.77
[Inhibition of venoconstriction induced by 5-hydroxytryptamine in man by methysergide (UMI-491) and other serotonin antagonists]. Boll Soc Ital Biol Sper (1964) 0.77
Intermittent hypoendorphinaemia in migraine attack. Cephalalgia (1982) 0.77
Dopamine and 5-HT supersensitivity in nonorganic central pain and in morphine abstinence: fortuitous or renal analogy? Adv Biochem Psychopharmacol (1980) 0.77
Modulation of excitatory amino acids pathway: a possible therapeutic approach to chronic daily headache associated with analgesic drugs abuse. Int J Clin Pharmacol Res (1997) 0.77
Phantom tooth diagnosis and an anamnestic focus on headache. N Y State Dent J (1993) 0.77
Negative modultors of excitatory amino acids in episodic and chronic migraine: preventing and reverting chronic migraine. Special lecture 7th INWIN Congress. Int J Clin Pharmacol Res (1998) 0.76
Increased adverse effects of opiates in migraine patients. Cephalalgia (1995) 0.76
Naloxone effectiveness on spontaneous and induced perceptive disorders in migraine. Headache (1983) 0.76
Impaired 5-hydroxytryptamine tachyphylaxis in migraine. Cephalalgia (1983) 0.76
[5-Hydroxytryptamine and physiopathology of pain; on a polyalgic syndrome in the course of therapy with para-chlorophenylalanine]. Clin Ter (1972) 0.76
Lateralisation of pain in cluster headache. Pain (1989) 0.76
Effects of calcium antagonists on serotonin and noradrenaline venoconstriction in humans. Clin Pharmacol Ther (1988) 0.76
Exploration of NMDA receptors in migraine: therapeutic and theoretic implications. Int J Clin Pharmacol Res (1995) 0.76
Monoamine oxidase defect in essential arterial hypertension. A single dose pargyline test. Monogr Neural Sci (1976) 0.76
Hypersensitivity to lysergic acid diethylamide (LSD-25) and psilocybin in essential headache. Experientia (1974) 0.76
[Anti-anginous effect of a non-coronaro-dilator sulfurated amino acid]. Clin Ter (1969) 0.76
Proceedings: Monoamine oxidase defect in essential arterial hypertension: 'a single dose pargyline test'. Br J Pharmacol (1974) 0.75